CJC-1295 (No DAC) + Ipamorelin + GHRP-2 Blend is supplied as one laboratory research vial containing CJC-1295 without DAC (Mod GRF 1-29) 3mg, Ipamorelin 3mg and GHRP-2 3mg, for 9mg combined nominal content. The CJC component is the supplier-confirmed no-DAC form, also named Mod GRF 1-29; no prolonged DAC half-life is claimed. The component amounts describe the listed material rather than a human dose or prepared solution concentration. The illustrated 3ml marking refers to container capacity.
This 9mg blend uses equal nominal masses of three components. Ipamorelin and GHRP-2 are both secretagogue-related materials, so three ingredients should not be presented as three independent mechanisms or an automatically superior effect. The label lists each amount to make the composition explicit.
GHRP-2/GHRH experiments studied combined secretion. Ipamorelin has separate preclinical secretagogue evidence; neither source validates this triple mixture. The references below explain the specific study context. No direct study of this exact supplied blend was identified in this review. Comparisons should distinguish individual-component evidence from mixture-specific stability, interactions and biological activity; a source link is not an endorsement or batch certification.
Match the product designation, individual component identities and stated amounts against the relevant analytical report before drawing laboratory conclusions. The SRP research chart is explanatory, and the COA, chromatography, mass-spectrometry and traceability illustrations are educational examples, not test results for this vial. For laboratory research only; not for human or veterinary use, diagnosis or treatment.
Reviews
There are no reviews yet.